Moreover, our studies showed the caerin peptides were i) functionally stable (Fig. 4); ii) were able to inhibit TC-1 tumour growth in vivo; iii) that the inhibition require adaptive immune responses (Fig. 4); and iv) increased the efficacy of the Ex/MPLA/anti-IL-10R vaccine (Fig. 4). Here, IL10RA is linked to neoplasm.